IMMUNE PHARMACEUTICALS INC
DelistedCIK 1208261fmd_1DK44YFR64AGQHPYB7MQ5BNKSEManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Sep 30, 2018, 35 periods
Latest annual · FY2017
Millions- Total revenues
- 0
- Gross profit
- 7
- Operating income
- (12)
- Net income
- (18)
- Free cash flow
- (12)
Latest quarter · Q3 FY2018
Millions- Total revenues
- 0
- Operating income
- (4)
- Net income
- (4)
- Free cash flow
- (2)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2014 to FY2017
- n/m
- Revenue, 5 yearsFY2012 to FY2017
- n/m
- Net income, 5 yearsFY2012 to FY2017
- n/m
IMMUNE PHARMACEUTICALS INC financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2017 | FY2016 | Change | Source |
|---|---|---|---|---|
| Revenue | $0 | $0 | 10-K 2018-04-02 · proof | |
| Operating income | -$12.1 million | -$27.3 million | 10-K 2018-04-02 · proof | |
| Net income | -$17.9 million | -$32.7 million | 10-K 2018-04-02 · proof | |
| Cash from operating activities | -$11.6 million | -$12.3 million | 10-K 2018-04-02 · proof | |
| Free cash flow | -$11.6 million | -$12.3 million | 10-K 2018-04-02 · proof | |
| Total assets | $28.6 million | $19.1 million | +49.7% | 10-K 2018-04-02 · proof |
| Total liabilities | $14.9 million | $16.6 million | -10.5% | 10-K 2018-04-02 · proof |
| Cash and cash equivalents | $6.8 million | $271,000 | +2,400.4% | 10-K 2018-04-02 · proof |
- What was IMMUNE PHARMACEUTICALS INC's revenue in fiscal 2017?
- IMMUNE PHARMACEUTICALS INC reported revenue of $0 for fiscal 2017 (the year ended Dec 31, 2017), against $0 the year before. Source: the 10-K filed with the SEC on Apr 2, 2018. SEC
- What was IMMUNE PHARMACEUTICALS INC's operating income in fiscal 2017?
- IMMUNE PHARMACEUTICALS INC reported operating income of -$12.1 million for fiscal 2017 (the year ended Dec 31, 2017), against -$27.3 million the year before. Source: the 10-K filed with the SEC on Apr 2, 2018. SEC
- What was IMMUNE PHARMACEUTICALS INC's net income in fiscal 2017?
- IMMUNE PHARMACEUTICALS INC reported net income of -$17.9 million for fiscal 2017 (the year ended Dec 31, 2017), against -$32.7 million the year before. Source: the 10-K filed with the SEC on Apr 2, 2018. SEC
- What was IMMUNE PHARMACEUTICALS INC's cash from operating activities in fiscal 2017?
- IMMUNE PHARMACEUTICALS INC reported cash from operating activities of -$11.6 million for fiscal 2017 (the year ended Dec 31, 2017), against -$12.3 million the year before. Source: the 10-K filed with the SEC on Apr 2, 2018. SEC
- What was IMMUNE PHARMACEUTICALS INC's free cash flow in fiscal 2017?
- IMMUNE PHARMACEUTICALS INC reported free cash flow of -$11.6 million for fiscal 2017 (the year ended Dec 31, 2017), against -$12.3 million the year before. Source: the 10-K filed with the SEC on Apr 2, 2018. SEC
- What are IMMUNE PHARMACEUTICALS INC's total assets?
- As of Dec 31, 2017, IMMUNE PHARMACEUTICALS INC reported total assets of $28.6 million, against $19.1 million a year earlier (+49.7%). Source: the 10-K filed with the SEC on Apr 2, 2018. SEC
- What are IMMUNE PHARMACEUTICALS INC's total liabilities?
- As of Dec 31, 2017, IMMUNE PHARMACEUTICALS INC reported total liabilities of $14.9 million, against $16.6 million a year earlier (-10.5%). Source: the 10-K filed with the SEC on Apr 2, 2018. SEC
- What are IMMUNE PHARMACEUTICALS INC's cash and cash equivalents?
- As of Dec 31, 2017, IMMUNE PHARMACEUTICALS INC reported cash and cash equivalents of $6.8 million, against $271,000 a year earlier (+2,400.4%). Source: the 10-K filed with the SEC on Apr 2, 2018. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1208261&period_type=annual&limit=5"Information only, not investment advice.